Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
about
Vitamin D receptor: A novel therapeutic target for kidney diseases.Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy.
P2860
Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Vitamin D receptor activator a ...... rationale and study protocol.
@en
type
label
Vitamin D receptor activator a ...... rationale and study protocol.
@en
prefLabel
Vitamin D receptor activator a ...... rationale and study protocol.
@en
P2093
P2860
P356
P1476
Vitamin D receptor activator a ...... rationale and study protocol.
@en
P2093
Charlotte A Keyzer
G Fenna van Breda
Gerjan Navis
Gozewijn D Laverman
Hiddo J Lambers Heerspink
Holland Nephrology Study (HONEST) Network
Maarten A de Jong
Marc G Vervloet
Marc Hemmelder
Martin H de Borst
P2860
P304
P356
10.1093/NDT/GFV033
P407
P577
2015-03-04T00:00:00Z